Anesthetic drugs and bariatric surgery

References

• Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin. Pharmacokinet.39(3), 215–231 (2000).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA291(10), 1238–1245 (2004).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States 2000. JAMA293(3), 293–294 (2005).
   PubMed Web of Science ®Google Scholar
• No authors listed. Gastrointestinal surgery for severe obesity. Consens Statement9(1), 1–20 (1991).
   Google Scholar
• Lemmens HJ, Brodsky JB, Bernstein DP. Estimating ideal body weight – a new formula. Obes. Surg.15(7), 1082–1083 (2005).
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes37(12), 1595–1607 (1988).
   PubMed Web of Science ®Google Scholar
• Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care28(11), 2745–2749 (2005).
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation110(10), 1245–1250 (2004).
   PubMed Web of Science ®Google Scholar
• Alexander JK, Dennis EW, Smith WG et al. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc. Res. Cent. Bull.1, 39–44 (1962).
   PubMedGoogle Scholar
• Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci.321(4), 225–236 (2001).
   PubMed Web of Science ®Google Scholar
• Koenig SM. Pulmonary complications of obesity. Am. J. Med. Sci.321(4), 249–279 (2001).
   PubMed Web of Science ®Google Scholar
• Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am. J. Med.75(1), 81–90 (1983).
   PubMedGoogle Scholar
• Pelosi P, Croci M, Ravagnan I, Vicardi P, Gattinoni L. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest109(1), 144–151 (1996).
   PubMed Web of Science ®Google Scholar
• Yap JC, Watson RA, Gilbey S, Pride NB. Effects of posture on respiratory mechanics in obesity. J. Appl. Physiol.79(4), 1199–1205 (1995).
   PubMed Web of Science ®Google Scholar
• Gilbert R, Sipple JH, Auchincloss JH Jr. Respiratory control and work of breathing in obese subjects. J. Appl. Physiol.16, 21–26 (1961).
   PubMed Web of Science ®Google Scholar
• Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir. Med.85(4), 309–311 (1991).
   PubMed Web of Science ®Google Scholar
• Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am. Rev. Respir. Dis.128(3), 501–506 (1983).
   PubMed Web of Science ®Google Scholar
• Kronenberg RS, Gabel RA, Severinghaus JW. Normal chemoreceptor function in obesity before and after ileal bypass surgery to force weight reduction. Am. J. Med.59(3), 349–353 (1975).
   PubMed Web of Science ®Google Scholar
• Burki NK, Baker RW. Ventilatory regulation in eucapnic morbid obesity. Am. Rev. Respir. Dis.129(4), 538–543 (1984).
   PubMedGoogle Scholar
• Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am. J. Med.59(3), 343–348 (1975).
   PubMed Web of Science ®Google Scholar
• Barrera F, Reidenberg MM, Winters WL, Hungspreugs S. Ventilation-perfusion relationships in the obese patient. J. Appl. Physiol.26(4), 420–426 (1969).
   PubMed Web of Science ®Google Scholar
• Barrera F, Hillyer P, Ascanio G, Bechtel J. The distribution of ventilation, diffusion, and blood flow in obese patients with normal and abnormal blood gases. Am. Rev. Respir. Dis.108(4), 819–830 (1973).
   PubMedGoogle Scholar
• Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation – a Pickwickian Syndrome, 1956. Obes. Res.2(4), 390–397 (1994).
   PubMedGoogle Scholar
• Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am. Rev. Respir. Dis.141(5 Pt 1), 1228–1231 (1990).
   PubMed Web of Science ®Google Scholar
• Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest97(1), 27–32 (1990).
   PubMed Web of Science ®Google Scholar
• He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest94(1), 9–14 (1988).
   PubMed Web of Science ®Google Scholar
• Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes. Surg.13(5), 676–683 (2003).
   PubMed Web of Science ®Google Scholar
• O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes. Surg.14(1), 23–26 (2004).
   PubMed Web of Science ®Google Scholar
• Gross JB, Bachenberg KL, Benumof JL et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on perioperative management of patients with obstructive sleep apnea. Anesthesiology104(5), 1081–1093 (2006).
   PubMed Web of Science ®Google Scholar
• Moretto M, Kupski C, Mottin CC et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and comorbidities. Obes. Surg.13(4), 622–624 (2003).
   PubMed Web of Science ®Google Scholar
• Dixon JB, Schachter LM, O’Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch. Intern. Med.161(1), 102–106 (2001).
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med.351(26), 2683–2693 (2004).
   PubMed Web of Science ®Google Scholar
• Noel PH, Pugh JA. Management of overweight and obese adults. BMJ325(7367), 757–761 (2002).
   PubMedGoogle Scholar
• Nguyen NT, Root J, Zainabadi K et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch. Surg.140(12), 1198–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet361(9374), 2032–2035 (2003).
   PubMed Web of Science ®Google Scholar
• Dundee JW, Hassard TH, McGowan WA, Henshaw J. The ‘induction’ dose of thiopentone. A method of study and preliminary illustrative results. Anaesthesia37(12), 1176–1184 (1982).
   PubMed Web of Science ®Google Scholar
• Bouillon T, Shafer SL. Does size matter? (Editorial views). Anesthesiology89(5), 557–560 (1998).
   PubMed Web of Science ®Google Scholar
• Wada DR, Bjorkman S, Ebling WF et al. Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology87(4), 884–899 (1997).
   PubMed Web of Science ®Google Scholar
• Jung D, Mayersohn M, Perrier D, Calkins J, Saunders R. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology56(4), 269–274 (1982).
   PubMed Web of Science ®Google Scholar
• Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology78(4), 657–665 (1993).
   PubMed Web of Science ®Google Scholar
• Kisor DF, Schmith VD. Clinical pharmacokinetics of cisatracurium besilate. Clin. Pharmacokinet.36(1), 27–40 (1999).
   PubMed Web of Science ®Google Scholar
• Alvarez AO, Cascardo A, Albarracin Menendez S, Capria JJ, Cordero RA. Total intravenous anesthesia with midazolam, remifentanil, propofol and cistracurium in morbid obesity. Obes. Surg.10(4), 353–360 (2000).
   PubMed Web of Science ®Google Scholar
• Leykin Y, Pellis T, Lucca M et al. The effects of cisatracurium on morbidly obese women. Anesth. Analg.99(4), 1090–1094 (2004).
   PubMed Web of Science ®Google Scholar
• Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS. Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth. Analg.83(5), 1076–1080 (1996).
   PubMed Web of Science ®Google Scholar
• Schwartz AE, Matteo RS, Ornstein E, Halevy JD, Diaz J. Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth. Analg.74(4), 515–518 (1992).
   PubMed Web of Science ®Google Scholar
• Leykin Y, Pellis T, Lucca M et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth. Analg.99(4), 1086–1089 (2004).
   PubMed Web of Science ®Google Scholar
• Bentley JB, Borel JD, Vaughan RW, Gandolfi AJ. Weight, pseudocholinesterase activity, and succinylcholine requirement. Anesthesiology57(1), 48–49 (1982).
   PubMed Web of Science ®Google Scholar
• Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth. Analg.102(2), 438–442 (2006).
   PubMed Web of Science ®Google Scholar
• Shibutani K, Inchiosa MA Jr, Sawada K, Bairamian M. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (“pharmacokinetic mass”). Anesthesiology101(3), 603–613 (2004).
   PubMed Web of Science ®Google Scholar
• Slepchenko G, Simon N, Goubaux B et al. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology98(1), 65–73 (2003).
   PubMedGoogle Scholar
• Egan TD, Huizinga B, Gupta SK et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology89(3), 562–573 (1998).
   PubMed Web of Science ®Google Scholar
• Cork RC, Vaughan RW, Bentley JB. General anesthesia for morbidly obese patients – an examination of postoperative outcomes. Anesthesiology54(4), 310–313 (1981).
   PubMed Web of Science ®Google Scholar
• Torri G, Casati A, Albertin A et al. Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients. J. Clin. Anesth.13(8), 565–570 (2001).
   PubMed Web of Science ®Google Scholar
• Strum EM, Szenohradszki J, Kaufman WA et al. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth. Analg.99(6), 1848–1853 (2004).
   PubMed Web of Science ®Google Scholar
• Arain SR, Barth CD, Shankar H, Ebert TJ. Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane. J. Clin. Anesth.17(6), 413–419 (2005).
   PubMed Web of Science ®Google Scholar
• Rigg JR, Jamrozik K, Myles PS et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet359(9314), 1276–1282 (2002).
   PubMed Web of Science ®Google Scholar
• Schumann R, Shikora S, Weiss JM et al. A comparison of multimodal perioperative analgesia to epidural pain management after gastric bypass surgery. Anesth. Analg.96(2), 469–474 (2003).
   PubMed Web of Science ®Google Scholar
• Schumann R, Jones SB, Ortiz VE et al. Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes. Res.13(2), 254–266 (2005).
   PubMedGoogle Scholar
• Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW. Anesthetic considerations for bariatric surgery. Anesth. Analg.95(6), 1793–1805 (2002).
   Google Scholar